We can easily redesign our existing gene panels to match your clinical practice.
We now offer an NGS panel for Hereditary Hemorrhagic Telangiectasia. Additionally, Noonan Syndrome test has been upgraded to Noonan Spectrum Disorders/Rasopathies test.
We are pleased to announce that our NGS panels now include CNV analysis. In addition, three new genes have been added to the Bardet-Biedl Syndrome panel.
Genetic testing for Prostate Cancer includes sequencing of the panel of genes and CNV analysis. Other NGS panels in the Asper Oncogenetics menu now also include CNV analysis.
We have added 14 new disease-causing genes to our spinocerebellar ataxia panel.
We have added a panel of Coagulation Disorders to our testing menu. The test consists of 17 genes associated with a wide variety of coagulation abnormalities.